Related Experiment Video
Updated: Dec 31, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Duodenal Ulceration in a Child with Coeliac Disease
Polina S Lototskaya1, Marina A Manina1, Aleksandr S Tertychnyy2
1Filatov Clinical Institute of Child Health, Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
Insights
Coeliac disease (CD) can present with rare duodenal ulcers, even in non-advanced cases. This case highlights the importance of considering CD in young patients with persistent gastrointestinal issues and peptic ulcers.
Area of Science:
- Gastroenterology
- Immunology
Background:
- Coeliac disease (CD) is a prevalent gluten-induced enteropathy affecting the small intestine.
- Peptic ulcer disease, particularly duodenal ulcers, is uncommon in non-advanced CD.
Observation:
- A 17-year-old female presented with a history of erosive gastritis and duodenitis since age 9.
- She developed a duodenal ulcer with bulb deformity at 16, initially attributed to Helicobacter pylori (HP) infection.
- Diagnosis of CD was confirmed via serology and intestinal biopsy despite atypical presentation.
Findings:
- This case demonstrates a rare presentation of CD with significant ulcerative lesions in the duodenum.
- Literature suggests an increased prevalence of peptic ulcer disease in CD patients.
- Comorbid CD and HP infection are reported, but CD-associated peptic ulcers are infrequently highlighted.
Implications:
- Increased clinical awareness is crucial for diagnosing CD in patients with unexplained peptic ulcer disease.
- Further research is needed to understand the mechanisms linking CD and peptic ulcer formation.
- Early identification of CD-related ulcerative lesions can prevent diagnostic delays and improve patient outcomes.
Abstract:
Coeliac disease (CD) is a gluten-dependent inflammatory disease of the small bowel that affects up to 1% of the global population. Herein, the presence of ulcers, erosions, or strictures in the duodenum for non-advanced cases of CD is a rarity. Case report: We present a clinical case of a 17-year-old girl, who from the age of 9, had suffered from erosive Helicobacter pylori (HP)-associated gastritis and erosive duodenitis. At 16, she was diagnosed with a duodenal ulcer, complicated by cicatricial deformity of the bulb. While an atypical course in the development of the disease had led to the initial delay in diagnosis, a serum study and an intestinal biopsy confirmed CD. Discussion: A recent study found an elevated rate of peptic ulcer disease in patients with CD. From literature searches, comorbid HP infection and CD have indeed been widely reported, whereas cases highlighting the prevalence of CD-associated peptic ulcers have been observed and reported in only a few instances. Consequently, greater awareness is warranted and must be exercised for identifying the origins of ulcerative lesions that may be CD-related or -derived.
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

